[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Genomic Prediction Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":123},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,41,66,87,107],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100526929","genetic-testing-in-elective-single-embryo-transfer-getset-a-randomized-clinical-trial-100526929",false,"NCT06141135","GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial","GETSET","Inclusion Criteria:\n\n* Women undergoing IVF of between 35 and 40 years of age at IVF cycle start\n* Utilization of Intracytoplasmic Sperm Injection ICSI (recommended) or ---Traditional IVF\n* Utilization of ejaculated or testicular sperm\n* Utilization of autologous or donor sperm\n* All Controlled Ovarian Hyperstimulation (COH) protocols\n\nExclusion Criteria:\n\n* Utilization of donor oocytes\n* Utilization of gestational carrier\n* Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages\n* Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers\n* Preimplantation genetic testing for monogenic\u002Fsingle gene disorders (PGT-M)\n* Translocation carriers","FEMALE","35 Years","40 Years",{"count":20,"type":21},240,"ESTIMATED","INTERVENTIONAL",[24],"NA","The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.",[27],"Infertility, Female","RECRUITING","2025-08-19",{"date":31,"type":32},"2025-08-26","ACTUAL",{"date":34,"type":32},"2023-11-15",{"date":36,"type":21},"2026-11-15",{"name":38,"class":39},"Genomic Prediction Inc.","INDUSTRY",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":48,"sex":49,"minAge":4,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":4,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":60,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":40},"100410745","cell-free-preimplantation-genetic-testing-100410745","NCT04628507","Cell Free Preimplantation Genetic Testing","Evaluation of Cell Free Preimplantation Genetic Testing","Inclusion Criteria:\n\n* Patients undergoing IVF electing to utilize LifeView testing (PGT) will be offered participation in this study.\n\nExclusion Criteria:\n\n* None",true,"ALL",{"count":51,"type":21},200,"OBSERVATIONAL","This study aims to develop preimplantation genetic testing methods from embryo culture media (cell free). Genetic testing of culture media will be compared to conventional methods based on embryo biopsies.",[27,55],"Infertility, Male",[57,58],"PGT","Noninvasive","NOT_YET_RECRUITING",{"date":31,"type":32},{"date":62,"type":21},"2026-06-11",{"date":64,"type":21},"2027-12-11",{"name":38,"class":39},{"id":67,"slug":68,"hasResults":11,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":48,"sex":49,"minAge":74,"maxAge":4,"enrollmentInfo":75,"targetDuration":4,"studyType":52,"phases":4,"briefSummary":77,"conditions":78,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":81,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":40},"100403069","embryo-health-study-100403069","NCT04528498","Embryo Health Study","The Embryo Health Study: Prospective Longitudinal Analysis of PGT-P","EHS","Inclusion Criteria:\n\n* All couples of Caucasian or East Asian ancestry above the age of 18 who elect to have PGT-A as part of their IVF treatment cycle.\n\nExclusion Criteria:\n\n* Any case where biological parental DNA is unavailable.\n* Any case involving PGT-M or PGT-SR.","18 Years",{"count":76,"type":21},500,"This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic counseling.",[79,80],"Infertility","Hereditary Diseases",{"date":31,"type":32},{"date":83,"type":32},"2020-12-01",{"date":85,"type":21},"2025-12-01",{"name":38,"class":39},{"id":88,"slug":89,"hasResults":11,"nctId":90,"briefTitle":91,"officialTitle":91,"acronym":4,"eligibilityCriteria":92,"healthyVolunteers":11,"sex":49,"minAge":4,"maxAge":4,"enrollmentInfo":93,"targetDuration":4,"studyType":52,"phases":4,"briefSummary":95,"conditions":96,"keywords":99,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":101,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":40},"100399183","follow-up-with-preimplantation-genetic-testing-patients-100399183","NCT04477863","Follow-up With Preimplantation Genetic Testing Patients","Inclusion Criteria:\n\n* Patients indicating willingness to participate in research during informed consent to perform PGT\n\nExclusion Criteria:\n\n* Patients who opted out of participating in research during informed consent to perform PGT",{"count":94,"type":21},10000,"The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. A licensed genetic counselor will conduct a recorded interview.",[79,97,98],"Genetic Disease","IVF",[57,100],"Follow-up",{"date":31,"type":32},{"date":103,"type":32},"2020-07-11",{"date":105,"type":21},"2050-12-31",{"name":38,"class":39},{"id":108,"slug":109,"hasResults":11,"nctId":110,"briefTitle":111,"officialTitle":112,"acronym":14,"eligibilityCriteria":113,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":114,"targetDuration":4,"studyType":22,"phases":115,"briefSummary":25,"conditions":116,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":117,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":40},"100375380","preimplantation-genetic-testing-in-women-of-advanced-maternal-age-100375380","NCT04167748","Preimplantation Genetic Testing in Women of Advanced Maternal Age","GEnetic Testing in Elective Single Embryo Transfer in Women of Advanced Maternal Age","Inclusion Criteria:\n\n* Women undergoing IVF of between 35 and 40 years of age at IVF cycle start\n* Utilization of Intracytoplasmic Sperm Injection ICSI\n* Utilization of ejaculated or testicular sperm\n* Utilization of autologous or donor sperm\n* All Controlled Ovarian Hyperstimulation (COH) protocols\n\nExclusion criteria:\n\n* Patients with anovulatory Polycystic ovarian syndrome (PCOS)\n* Utilization of donor oocytes\n* Utilization of gestational carrier\n* Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages\n* Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers",{"count":20,"type":21},[24],[27],{"date":31,"type":32},{"date":119,"type":32},"2021-03-05",{"date":121,"type":21},"2026-12",{"name":38,"class":39},""]